Tryptophan depletion in patients with Selective Serotonin Reuptake Inhibitor (SSRI)-remitted anxiety disorders

Not Applicable

Completed

• Conditions: Obsessive-compulsive disorder (OCD); Generalised anxiety disorder (GAD).; Mental and Behavioural Disorders; Obsessive compulsive disorder

• Registration Number: ISRCTN01523262
• Lead Sponsor: Raine Medical Research Foundation (Australia)

Brief Summary

2009 results in https://pubmed.ncbi.nlm.nih.gov/19936713/ (added 12/01/2021)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-05-10
• Study Completion: 2006-12-31
• Last Update Posted: 25 January 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

Study 1: Primary diagnosis of obsessive-compulsive disorder (OCD), currently remitted with SSRI therapy
Study 2: Primary diagnosis of generalised anxiety disorder (GAD), currently remitted with SSRI therapy
Aged 18-65
Able and willing to give informed consent prior to participation

Exclusion Criteria

1. No significant co-morbid anxiety disorder or other psychiatric disorder including alcohol or drug dependence
2. No major depressive episode with past 6 months
3. No significant other illness
4. No significant other medication therapy
5. No psychological therapy applied this episode

Study & Design

• Study Type: Interventional
• Study Design: Not specified